Taxus Cardium Pharmaceuticals Group Inc (OTC Pink - Limited Information:CRXM)

0.3535
Delayed Data
As of Apr 24
 -0.0065 / -1.81%
Today’s Change
0.07
Today|||52-Week Range
0.78
+99.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.4M

Company Description

Taxus Cardium Pharmaceuticals Group, Inc. is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses having the potential to address significant unmet medical needs, and definable pathways to commercialization, partnering and other economic monetization. It operates through two segments: Pharmaceutical Products and Nutraceutical Products: The Pharmaceutical segment engages in the development, testing and clinical trials of Generx and Excellagen products. The Nutraceutical segment engages in the purchasing, packaging, selling and distribution of the To Go Brands portfolio of products. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde on December 22, 2003 and is headquartered in San Diego, CA.

Contact Information

Taxus Cardium Pharmaceuticals Group, Inc.
11750 Sorrento Valley Road
San Diego California 92121
P:(858) 436-1000
Investor Relations:
(858) 436-1018

Employees

Shareholders

Individual stakeholders1.25%
Mutual fund holders--
Other institutional--

Top Executives

Christopher J. ReinhardChairman, President, CEO & Treasurer
Ted WilliamsVP-Manufacturing & Technical Operations
Gabor M. RubanyiChief Scientific Officer
Lois A. ChandlerVice President-Biologics Development
Mark McCutchenVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account